If we can sequence a patient's tumor and their blood in real time and have a treatment decision by the next morning, we will save lives. That is the system we are building.
We were not trying to make a new drug. We were trying to make an old drug tolerable. That turned out to be a bigger solution than anyone expected.
A free press is not a luxury. It is essential infrastructure — as important as roads and bridges. That is why I bought the Los Angeles Times.
I never set out to become a billionaire. I set out to solve a problem. The financial outcome was a consequence of getting the science right.
Everyone had accepted that the reactions were part of the treatment. Nobody stopped to ask whether the solvent itself was the problem. That question changed everything.